The use of Kuraderm drug in the treatment of basal cell carcinoma of the head and neck

Basal cell carcinoma is one of the most common malignancies. Despite a wide range of treatment options and relatively good prognosis of the disease, there may be restrictions on the use of standard methods of treatment because of elderly patients, their physical condition and characteristics of the tumor localization. We provide clinical examples of successful treatment of basal cell carcinoma of the head and neck with Kuraderm BEC5. This is a drug with anti-tumor activity for topical use made on the basis of glycoalkaloids of plants of nightshade family

First results studying the transmutation of (129)I, (237)Np, (238)Pu, and (239)Pu in the irradiation of an extended (nat)U/Pb-assembly with 2.52 GeV deuterons

An extended U/Pb-assembly was irradiated with an extracted beam of 2.52 GeV deuterons from the Nuclotron accelerator of the Laboratory of High Energies within the JINR in Dubna, Russia. The lay-out of this experiment and first results are reported. The Pb-target (diameter 8.4 cm, length 45.6 cm) is surrounded by a (nat)U-blanket (206.4 kg) and used for transmutation studies of hermetically sealed radioactive samples of (129)I, (237)Np, (238)Pu and (239)Pu. Estimates of transmutation rates were obtained as result of measurements of gamma-activities of the samples. Information about the spatial and energy distribution of neutrons in the volume of the lead target and the uranium blanket was obtained with sets of activation threshold detectors (Al, Y and Au) and solid state nuclear track detectors (SSNTD). An electronic (3)He neutron detector was tested on-line. A comparison of experimental data with theoretical model calculations using the MCNPX program was performed yielding satisfactory results